BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30
• 31

• Biotech Bay

  Kindred Biosciences to Present at Jefferies 2018 Global Healthcare Conference and 8th Annual LD Micro Invitational Conference

  Kindred Biosciences, Inc. will present at the 8th Annual LD Micro Invitational Conference

  May 29, 2018

   · 

  1 min read
• Business

  Stanley Bergman Addresses Western University of Health Sciences Dental, Pharmacy, and Veterinary Graduates

  Stanley M. Bergman, Chairman of the Board and CEO of Henry Schein, Inc. (Nasdaq: HSIC), delivered the commencement addresses to three graduating classes at the Western University of Health Sciences.

  May 29, 2018

   · 

  3 min read
• Business

  Pear Therapeutics to Present at Jefferies 2018 Healthcare Conference

  Pear Therapeutics, Inc. announced that Corey McCann, M.D., Ph.D., President and CEO, will present at the Jefferies 2018 Healthcare Conference.

  May 29, 2018

   · 

  1 min read
• Business

  Adaptive Biotechnologies Announces a Collaboration with Sanofi to Use Adaptive’s clonoSEQ® Assay to Measure Minimal Residual Disease in Active and Future Isatuximab Multiple Myeloma Trials

  Adaptive Biotechnologies announced today that it entered into an agreement with Sanofi to utilize Adaptive’s NGS-based clonoSEQ® Assay to assess minimal residual disease (MRD) status in response to isatuximab.

  May 29, 2018

   · 

  3 min read
• Business

  Optovue Announces Retirement of Prominent Industry Veteran John Hawley

  Optovue today announced the retirement of renowned industry veteran John Hawley, the company’s senior vice president of global sales.

  May 29, 2018

   · 

  2 min read
• Drug Development

  NeoImmuneTech Announces Initiation of HyLeukin-7 Clinical Development for Cancer Patients in the U.S.

  NeoImmuneTech, Inc. announced today the initiation of its first U.S. clinical trial.

  May 29, 2018

   · 

  3 min read
• Genetown

  New Study Demonstrates Feasibility of Using RenalGuard-Guided Diuretic Therapy for Acute Heart Failure Patients

  RenalGuard Solutions™, Inc. announced new clinical study results demonstrating the feasibility of using RenalGuard®-Guided Diuretic Therapy.

  May 29, 2018

   · 

  4 min read
• Policy

  Lumendi Receives FDA 510(k) Clearance for DiLumen Is™ Endolumenal Interventional Scissors

  Connecticut-based medical device innovator Lumendi, LLC has announced it has received United States Food and Drug Administration (FDA) 510(k) clearance for the DiLumen Is™ Endolumenal Interventional Scissors.

  May 29, 2018

   · 

  4 min read
• Pharm Country

  Cannabis and CBD Markets are Set to Increase in Value

  According to a report by Hexa Research, the U.S. medical cannabis market is projected to reach $19.48 billion by 2024.

  May 29, 2018

   · 

  10 min read
• Biotech Beach

  Medical Marijuana, Inc. CEO to Speak on Medical Cannabis Research at 5th Annual Cannabis World Congress and Business Expo in New York

  Medical Marijuana, Inc. announced that at the 5th Annual Cannabis World Congress and Business Expo (CWCBE), taking place in New York City from May 31-June 2, the company’s Chief Executive Officer Dr. Stuart Titus will speak on medical cannabis and cannabidiol (CBD) research on May 31.

  May 29, 2018

   · 

  4 min read